Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

3 Carolina seniors win Rhodes scholarships
For the second time ever, the University of North Carolina has three Rhodes scholars in the same year. Seniors Rotimi Kukoyi and Gabrielle Moreau received...
Mon Nov 17, 2025

UNC expands support for military and student veterans with success center
UNC-Chapel Hill unveiled its expanded Military and Veteran Student Success Center this week, a move aimed at better supporting students who are vets and their...
Sun Nov 16, 2025

Get to know the trees on UNC's campus
We seek refuge from the hot sun underneath them, stop and take photos when they change colors in fall and marvel at their height. There...
Sun Nov 16, 2025

Archaeological digs at UNC's New East yield centuries-old relics
On a sunny morning in late April, a group of North Carolina faculty and students hunched down on the ground outside New East and sifted...
Wed Nov 12, 2025